COLETTE JOHNSON: Open Payments
NPI 1154179190 · NORWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $745 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $58 |
| Ascendis Pharma Endocrinology Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $27 |
| Amphastar Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: PANGEA, Yorvipath, Kerendia, QUTENZA, JARDIANCE, Dexcom G6 Transmitter, GVOKE HYPOPEN, AFREZZA.
Industry payments across NY — which companies pay providers there.
